Similar articles

• The trials of anakinra.

  Burls A, Jobanputra P. Burls A, et al. Lancet. 2004 Sep 4-10;364(9437):827-8. doi: 10.1016/S0140-6736(04)16999-7. Lancet. 2004. PMID: 15351176 No abstract available.
• The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.

  Cohen SB. Cohen SB. Rheum Dis Clin North Am. 2004 May;30(2):365-80, vii. doi: 10.1016/j.rdc.2004.01.005. Rheum Dis Clin North Am. 2004. PMID: 15172046 Review.
• Anakinra: new preparation. Weakly effective in rheumatoid arthritis.

  [No authors listed] [No authors listed] Prescrire Int. 2004 Apr;13(70):43-5. Prescrire Int. 2004. PMID: 15148945
• [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].

  Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ. Zoń-Giebel A, et al. Przegl Lek. 2002;59(11):916-8. Przegl Lek. 2002. PMID: 12715722 Review. Polish.
• Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.

  Furst DE. Furst DE. Clin Ther. 2004 Dec;26(12):1960-75. doi: 10.1016/j.clinthera.2004.12.019. Clin Ther. 2004. PMID: 15823761 Review.